Abstract
The earliest characteristic of the liver in Wilson disease (WD) includes steatosis. A genetic polymorphism in rs738409, in the patatin-like phospholipase domain (PNPLA3), seems to have a role in NAFLD and a recent paper also support its influence in steatosis in WD patients. This study evaluated the role of PNPLA3 variant in large cohort of WD patients as potential modifiers of metabolic syndrome and neurologic phenotype.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
